{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:32:31Z","timestamp":1791203551255,"version":"4.2.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.phrs.2017.03.017","type":"journal-article","created":{"date-parts":[[2017,3,19]],"date-time":"2017-03-19T10:30:51Z","timestamp":1489919451000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["The interplay between Angiotensin II, TLR4 and hypertension"],"prefix":"10.1016","volume":"120","author":[{"given":"Vinicia Campana","family":"Biancardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Facholi","family":"Bomfim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Luis","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Al-Gassimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenia Pedrosa","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.114.04012","article-title":"Trends in blood pressure among adults with hypertension: United States, 2003 to 2012","volume":"65","author":"Yoon","year":"2015","journal-title":"Hypertension"},{"issue":"3 Pt 2","key":"10.1016\/j.phrs.2017.03.017_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/01.HYP.27.3.465","article-title":"Mechanisms for inducible control of angiotensinogen gene transcription","volume":"27","author":"Brasier","year":"1996","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11906-013-0413-9","article-title":"Innate immunity in hypertension","volume":"16","author":"Mian","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0025","doi-asserted-by":"crossref","first-page":"R501","DOI":"10.1152\/ajpregu.00194.2014","article-title":"Toll-like receptors and hypertension","volume":"307","author":"Singh","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0035","doi-asserted-by":"crossref","first-page":"H184","DOI":"10.1152\/ajpheart.00328.2013","article-title":"Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension","volume":"306","author":"McCarthy","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2017.03.017_bib0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/CS20110523","article-title":"Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats","volume":"122","author":"Bomfim","year":"2012","journal-title":"Clin. Sci. (Lond)"},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin-angiotensin system in vascular inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0055","doi-asserted-by":"crossref","first-page":"H111","DOI":"10.1152\/ajpheart.01061.2003","article-title":"Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB\/IkappaB system","volume":"288","author":"Sanz-Rosa","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/HYPERTENSIONAHA.110.158071","article-title":"Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2\/signal transducer and activator of transcription 3 activation","volume":"56","author":"Brands","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.111.173328","article-title":"Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage","volume":"59","author":"Zhang","year":"2012","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.phrs.2017.03.017_bib0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ajh.2011.113","article-title":"Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans","volume":"24","author":"Chamarthi","year":"2011","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cvr\/cvp073","article-title":"Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension","volume":"82","author":"Kang","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0080","doi-asserted-by":"crossref","first-page":"e63847","DOI":"10.1371\/journal.pone.0063847","article-title":"Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension","volume":"8","author":"Sriramula","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0735-1097(03)00845-3","article-title":"Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade","volume":"42","author":"Schiffrin","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.HYP.27.1.32","article-title":"Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension","volume":"27","author":"Tschudi","year":"1996","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.phrs.2017.03.017_bib0095","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","article-title":"Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms","volume":"86","author":"Ruiz-Ortega","year":"2000","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.107.103192","article-title":"Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension","volume":"51","author":"Yogi","year":"2008","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.RES.0000161257.02571.4b","article-title":"NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II","volume":"96","author":"Sun","year":"2005","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0110","doi-asserted-by":"crossref","first-page":"H2271","DOI":"10.1152\/ajpheart.00949.2004","article-title":"Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM","volume":"288","author":"Gao","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/HYPERTENSIONAHA.109.142646","article-title":"Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system","volume":"55","author":"Lob","year":"2010","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0120","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MNH.0000000000000146","article-title":"Hypertension and immunity: mechanisms of T cell activation and pathways of hypertension","volume":"24","author":"Abais-Battad","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2017.03.017_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12026-014-8548-6","article-title":"The immune system and hypertension","volume":"59","author":"Singh","year":"2014","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cphy.c130040","article-title":"Classical Renin-Angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr. Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension","volume":"17","author":"Munoz-Durango","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","article-title":"Pathophysiology of hypertensive renal damage: implications for therapy","volume":"44","author":"Bidani","year":"2004","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.phrs.2017.03.017_bib0150","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/BF03402088","article-title":"Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress","volume":"8","author":"Lodha","year":"2002","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1681\/ASN.2005070699","article-title":"Angiotensin II upregulates toll-like receptor 4 on mesangial cells","volume":"17","author":"Wolf","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9\u201310","key":"10.1016\/j.phrs.2017.03.017_bib0160","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1089\/ars.2005.7.1337","article-title":"Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis","volume":"7","author":"Wolf","year":"2005","journal-title":"Antioxid. Redox. Signal"},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0165","first-page":"1975","article-title":"Role of apoptosis in renal injury","volume":"54","author":"Sugiyama","year":"1996","journal-title":"Nihon Rinsho"},{"issue":"10","key":"10.1016\/j.phrs.2017.03.017_bib0170","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox. Signal"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0175","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1523-1755.2002.00365.x","article-title":"Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors","volume":"61","author":"Wolf","year":"2002","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.017_bib0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpcardio0938","article-title":"Mechanisms of disease: Toll-like receptors in cardiovascular disease","volume":"4","author":"Frantz","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2017.03.017_bib0185","doi-asserted-by":"crossref","first-page":"181394","DOI":"10.1155\/2012\/181394","article-title":"The emerging role of TLR and innate immunity in cardiovascular disease","volume":"2012","author":"Spirig","year":"2012","journal-title":"Cardiol. Res. Pract."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0190","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.2007090982","article-title":"TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity","volume":"19","author":"Zhang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0195","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jss.2009.09.053","article-title":"Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis","volume":"168","author":"Campbell","year":"2011","journal-title":"J. Surg. Res."},{"issue":"9","key":"10.1016\/j.phrs.2017.03.017_bib0200","volume":"3","author":"Souza","year":"2015","journal-title":"TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression Physiol. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1189\/jlb.1209775","article-title":"Endogenous ligands of TLR2 and TLR4: agonists or assistants?","volume":"87","author":"Erridge","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yexcr.2015.05.011","article-title":"Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells","volume":"335","author":"Nair","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.017_bib0215","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/01.ASN.0000121781.89599.16","article-title":"Signaling danger: toll-like receptors and their potential roles in kidney disease","volume":"15","author":"Anders","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2008.04.010","article-title":"Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo","volume":"202","author":"Dasu","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2009.01.035","article-title":"Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4\/MyD88 pathway","volume":"380","author":"Lv","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2017.03.017_bib0230","doi-asserted-by":"crossref","first-page":"e0142456","DOI":"10.1371\/journal.pone.0142456","article-title":"TAK-242, a toll-like receptor 4 antagonist, protects against aldosterone-induced cardiac and renal injury","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2017.03.017_bib0235","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","article-title":"High mobility group box protein 1 (HMGB1): the prototypical endogenous danger molecule","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.2000.2.1.13","article-title":"Inflammation influences vascular remodeling through AT2 receptor expression and signaling","volume":"2","author":"Akishita","year":"2000","journal-title":"Physiol. Genomics"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","article-title":"Angiotensin II and vascular injury","volume":"16","author":"Montezano","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.phrs.2017.03.017_bib0250","doi-asserted-by":"crossref","first-page":"689360","DOI":"10.1155\/2014\/689360","article-title":"The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflam."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0255","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00041552-200503000-00007","article-title":"Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II","volume":"14","author":"Touyz","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4\u20136","key":"10.1016\/j.phrs.2017.03.017_bib0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000218173","article-title":"Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells","volume":"23","author":"Ji","year":"2009","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.phrs.2017.03.017_bib0270","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13117","article-title":"Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension","author":"Hernanz","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.03.017_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.12.001","article-title":"Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats","volume":"122","author":"Bomfim","year":"2015","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.017_bib0280","doi-asserted-by":"crossref","first-page":"e104020","DOI":"10.1371\/journal.pone.0104020","article-title":"Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production","volume":"9","author":"De Batista","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.phrs.2017.03.017_bib0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/hr.2015.55","article-title":"TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase","volume":"38","author":"Nakashima","year":"2015","journal-title":"Hypertens. Res."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0290","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cvr\/cvt265","article-title":"Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension","volume":"101","author":"Sollinger","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0295","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(92)91138-5","article-title":"Intravenous angiotensin II induces Fos-immunoreactivity in circumventricular organs of the lamina terminalis","volume":"594","author":"McKinley","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2017.03.017_bib0300","doi-asserted-by":"crossref","first-page":"175428","DOI":"10.1155\/2013\/175428","article-title":"Immunohistochemical localization of AT1a, AT1b, and AT2 Angiotensin II receptor subtypes in the rat adrenal, pituitary, and brain with a perspective commentary","volume":"2013","author":"Premer","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.phrs.2017.03.017_bib0305","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1111\/j.1440-1681.1996.tb02821.x","article-title":"Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain","volume":"3","author":"McKinley","year":"1996","journal-title":"Clin. Exp. Pharmacol. Physiol. Suppl."},{"issue":"11","key":"10.1016\/j.phrs.2017.03.017_bib0310","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0315","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCRESAHA.110.226977","article-title":"Involvement of the brain (pro)renin receptor in cardiovascular homeostasis","volume":"107","author":"Shan","year":"2010","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0320","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00418-004-0684-y","article-title":"Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats","volume":"122","author":"Ueno","year":"2004","journal-title":"Histochem. Cell. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.017_bib0325","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1549-8719.2010.00060.x","article-title":"Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension","volume":"17","author":"Vital","year":"2010","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/15734021113099990003","article-title":"RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects","volume":"9","author":"Pelisch","year":"2013","journal-title":"Curr. Hypertens. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0335","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ajh.2010.241","article-title":"Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats","volume":"24","author":"Pelisch","year":"2011","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0340","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","article-title":"Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier","volume":"63","author":"Biancardi","year":"2014","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.phrs.2017.03.017_bib0345","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1523\/JNEUROSCI.6262-11.2012","article-title":"Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension","volume":"32","author":"Capone","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.017_bib0350","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/HYPERTENSIONAHA.115.03624","article-title":"Angiotensin-II, the brain, and hypertension: an update","volume":"66","author":"Young","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.03.017_bib0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-9081-6-64","article-title":"Central nitrergic system regulation of neuroendocrine secretion, fluid intake and blood pressure induced by angiotensin-II","volume":"6","author":"Reis","year":"2010","journal-title":"Behav. Brain Funct."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0360","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.111.169748","article-title":"Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension","volume":"57","author":"Zubcevic","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.017_bib0370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","article-title":"T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?","volume":"31","author":"Appel","year":"2010","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0380","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbadis.2015.10.018","article-title":"Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke","volume":"1862","author":"Lopes Pinheiro","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0385","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.110.150409","article-title":"Brain microglial cytokines in neurogenic hypertension","volume":"56","author":"Shi","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0400","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","article-title":"Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus","volume":"310","author":"Biancardi","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0405","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.115.05333","article-title":"Microglia participate in neurogenic regulation of hypertension","volume":"66","author":"Shen","year":"2015","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.017_bib0410","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri3086","article-title":"Microglial cell origin and phenotypes in health and disease","volume":"11","author":"Saijo","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"14","key":"10.1016\/j.phrs.2017.03.017_bib0415","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1073\/pnas.1432609100","article-title":"Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway","volume":"100","author":"Lehnardt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6\u20137","key":"10.1016\/j.phrs.2017.03.017_bib0420","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","article-title":"Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery","volume":"29","author":"Benicky","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.017_bib0425","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT1 receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0430","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cvr\/cvu067","article-title":"Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension","volume":"103","author":"Dange","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2017.03.017_bib0435","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.taap.2016.06.014","article-title":"TLR4\/MyD88\/NF-kappaB signaling and PPAR-gamma within the paraventricular nucleus are involved in the effects of telmisartan in hypertension","volume":"305","author":"Li","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2017.03.017_bib0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-015-0242-7","article-title":"Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension","volume":"12","author":"Dange","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0445","doi-asserted-by":"crossref","first-page":"e0122850","DOI":"10.1371\/journal.pone.0122850","article-title":"Toll-like receptor 4 promotes autonomic dysfunction, inflammation and microglia activation in the hypothalamic paraventricular nucleus: role of endoplasmic reticulum stress","volume":"10","author":"Masson","year":"2015","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.017_bib0450","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1172\/JCI64583","article-title":"ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension","volume":"122","author":"Young","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0455","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/HYPERTENSIONAHA.111.00469","article-title":"Redox-sensitive endoplasmic reticulum stress and autophagy at rostral ventrolateral medulla contribute to hypertension in spontaneously hypertensive rats","volume":"61","author":"Chao","year":"2013","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.017_bib0460","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.RES.0000043501.47934.FA","article-title":"Superoxide mediates the actions of angiotensin II in the central nervous system","volume":"91","author":"Zimmerman","year":"2002","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0465","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.0000135483.12297.e4","article-title":"Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system","volume":"95","author":"Zimmerman","year":"2004","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0470","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/glia.22765","article-title":"Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation","volume":"63","author":"Rodriguez-Perez","year":"2015","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0475","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","article-title":"Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS","volume":"31","author":"Rodriguez-Pallares","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0485","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.taap.2014.02.002","article-title":"Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension","volume":"276","author":"Su","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2017.03.017_bib0490","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1742-2094-9-212","article-title":"Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation","volume":"9","author":"Wu","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0495","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells","volume":"29","author":"Fleegal-DeMotta","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0500","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.neuroscience.2010.09.029","article-title":"Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress","volume":"171","author":"Zhang","year":"2010","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.017_bib0505","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10571-009-9446-7","article-title":"Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia","volume":"30","author":"Sumi","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2017.03.017_bib0510","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-9255-8-7","article-title":"Endotoxin-activated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways","volume":"8","author":"Kacimi","year":"2011","journal-title":"J. Inflamm. (Lond)"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0515","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2050-490X-2-2","article-title":"Hypothalamic paraventricular nucleus activation contributes to neurohumoral excitation in rats with heart failure","volume":"2","author":"Kang","year":"2014","journal-title":"Regen. Med. Res."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0520","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.017_bib0525","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000102551","article-title":"Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites","volume":"27","author":"Bondeva","year":"2007","journal-title":"Am. J. Nephrol."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.017_bib0530","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/ndt\/gfs260","article-title":"The pathogenic role of the renal proximal tubular cell in diabetic nephropathy","volume":"27","author":"Tang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2017.03.017_bib0535","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.fitote.2016.06.010","article-title":"Genipin ameliorates hypertension-induced renal damage via the angiotensin II-TLR\/MyD88\/MAPK pathway","volume":"112","author":"Yu","year":"2016","journal-title":"Fitoterapia"},{"issue":"8","key":"10.1016\/j.phrs.2017.03.017_bib0540","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00011-009-0012-z","article-title":"Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells","volume":"58","author":"Wu","year":"2009","journal-title":"Inflamm. Res."},{"issue":"Pt 2","key":"10.1016\/j.phrs.2017.03.017_bib0545","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/BJ20041243","article-title":"Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression","volume":"387","author":"Roger","year":"2005","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0550","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjp.0707454","article-title":"Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats","volume":"152","author":"Dai","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.017_bib0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/jmcc.2000.1272","article-title":"Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors","volume":"33","author":"Saito","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"31","key":"10.1016\/j.phrs.2017.03.017_bib0560","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1073\/pnas.1511794112","article-title":"Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal","volume":"112","author":"De","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.phrs.2017.03.017_bib0565","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1111\/bph.13117","article-title":"Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension","volume":"172","author":"Hernanz","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"181","key":"10.1016\/j.phrs.2017.03.017_bib0570","doi-asserted-by":"crossref","first-page":"PE16","DOI":"10.1126\/stke.2003.181.pe16","article-title":"Angiotensin type 2 receptor (AT2R): a challenging twin","volume":"2003","author":"Berk","year":"2003","journal-title":"Sci. STKE"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.017_bib0575","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.017_bib0580","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.micinf.2006.02.024","article-title":"Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4","volume":"8","author":"de Graaf","year":"2006","journal-title":"Microbes Infect."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816309100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816309100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T17:28:22Z","timestamp":1658856502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816309100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":116,"alternative-id":["S1043661816309100"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.03.017","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interplay between Angiotensin II, TLR4 and hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}